PHACTR1 is associated with disease progression in Chinese Moyamoya disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PHACTR1 is associated with disease progression in Chinese Moyamoya disease
Authors
Keywords
-
Journal
PeerJ
Volume 8, Issue -, Pages e8841
Publisher
PeerJ
Online
2020-05-05
DOI
10.7717/peerj.8841
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical and Molecular Features of 5 European Multigenerational Families With Moyamoya Angiopathy
- (2019) Lou Grangeon et al. STROKE
- The 3′-end region of the human PDGFR-β core promoter nuclease hypersensitive element forms a mixture of two unique end-insertion G-quadruplexes
- (2018) Buket Onel et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Long-Term Outcomes After Combined Revascularization Surgery in Adult Hemorrhagic Moyamoya Disease
- (2018) Hanqiang Jiang et al. World Neurosurgery
- HLA-DRB1 polymorphisms and alopecia areata disease risk
- (2018) Conghua Ji et al. MEDICINE
- Moyamoya Disease in Pregnancy: A 20-Year Single-Center Experience and Literature Review
- (2018) Yoshihide Inayama et al. World Neurosurgery
- Childhood Moyamoya: Looking Back to the Future
- (2018) Nomazulu Dlamini et al. PEDIATRIC NEUROLOGY
- Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians
- (2017) Stéphanie Guey et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Exome Sequencing Identified CCER2 as a Novel Candidate Gene for Moyamoya Disease
- (2017) Maki Mukawa et al. Journal of Stroke & Cerebrovascular Diseases
- Generation of an induced pluripotent stem cell line (CSCRMi001-A) from a patient with a new type of limb-girdle muscular dystrophy (LGMD) due to a missense mutation in POGLUT1 ( Rumi )
- (2017) Jianbo Wu et al. Stem Cell Research
- Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study
- (2017) Lian Duan et al. STROKE
- Exome Sequencing Identified CCER2 as a Novel Candidate Gene for Moyamoya Disease
- (2017) Maki Mukawa et al. Journal of Stroke & Cerebrovascular Diseases
- NSD1 encoding a histone methyltransferase exhibits frameshift mutations in colorectal cancers
- (2016) Yun Sol Jo et al. PATHOLOGY
- PHACTR1 Gene Polymorphism Is Associated with Increased Risk of Developing Premature Coronary Artery Disease in Mexican Population
- (2016) Nonanzit Pérez-Hernández et al. International Journal of Environmental Research and Public Health
- Moyamoya: defining current knowledge gaps
- (2015) Vijeya Ganesan et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Paired exome analysis of Barrett's esophagus and adenocarcinoma
- (2015) Matthew D Stachler et al. NATURE GENETICS
- Allorecognition of HLA-DP by CD4+ T cells is affected by polymorphism in its alpha chain
- (2014) Nina Lauterbach et al. MOLECULAR IMMUNOLOGY
- An update on the diagnosis and treatment of adult Moyamoya disease taking into consideration controversial issues
- (2014) Jeong Eun Kim et al. NEUROLOGICAL RESEARCH
- Dvl2-Dependent Activation of Daam1 and RhoA Regulates Wnt5a-Induced Breast Cancer Cell Migration
- (2012) Yichao Zhu et al. PLoS One
- Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development
- (2011) Wanyang Liu et al. PLoS One
- Epidemiological and clinical features of Moyamoya disease in Nanjing, China
- (2009) Wei Miao et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Moyamoya Disease and Moyamoya Syndrome
- (2009) R. Michael Scott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Moyamoya disease: current concepts and future perspectives
- (2008) Satoshi Kuroda et al. LANCET NEUROLOGY
- Moyamoya Disease in Europeans
- (2008) Markus Kraemer et al. STROKE
- Prevalence and Clinicoepidemiological Features of Moyamoya Disease in Japan
- (2007) Shinichi Kuriyama et al. STROKE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started